A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)

NCT04439071 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

189

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Pneumonia
COVID-19
Coronavirus

Interventions

DRUG: PTC299
OTHER: SOC
DRUG: Placebo

Sponsor

PTC Therapeutics